Puracap Pharm Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PURACAP PHARM LLC
PURACAP PHARM LLC has seven approved drugs.
Drugs and US Patents for Puracap Pharm Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Puracap Pharm Llc | OMEGA-3-ACID ETHYL ESTERS | omega-3-acid ethyl esters | CAPSULE;ORAL | 210093-001 | Jun 15, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Puracap Pharm Llc | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 208363-001 | Mar 15, 2018 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Puracap Pharm Llc | PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 206738-002 | Oct 6, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

